Gabriel Pascual

6.6k total citations · 4 hit papers
22 papers, 5.4k citations indexed

About

Gabriel Pascual is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Gabriel Pascual has authored 22 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Physiology. Recurrent topics in Gabriel Pascual's work include Peroxisome Proliferator-Activated Receptors (8 papers), NF-κB Signaling Pathways (6 papers) and interferon and immune responses (3 papers). Gabriel Pascual is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), NF-κB Signaling Pathways (6 papers) and interferon and immune responses (3 papers). Gabriel Pascual collaborates with scholars based in United States, Netherlands and Belgium. Gabriel Pascual's co-authors include Christopher K. Glass, Michael G. Rosenfeld, Sumito Ogawa, Mei Li, Timothy M. Willson, Amir Gamliel, Valentina Perissi, Mercedes Ricote, Andrew C. Li and David W. Rose and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gabriel Pascual

22 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ

2005 1.0k citations Gabriel Pascual, Sumito Ogawa et al. Nature profile →
15-Deoxy-Δ ^12,14 -prostaglandin J ₂ inhibits multiple steps in the NF-κB signaling pathway

2000 906 citations Gabriel Pascual, Mercedes Ricote et al. profile →
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription

2008 805 citations Xiangting Wang, S Arai et al. Nature profile →
Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors

2005 533 citations Sumito Ogawa, Jean Lozach et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gabriel Pascual United States	16	3.6k	1.5k	1.3k	651	610	22	5.4k
Adrian T. Ting United States	31	3.9k 1.1×	1.5k 1.0×	2.7k 2.1×	609 0.9×	427 0.7×	58	6.3k
Carolyn Kelly United States	20	3.3k 0.9×	758 0.5×	1.2k 0.9×	832 1.3×	569 0.9×	43	5.1k
Lih‐Ling Lin United States	29	3.8k 1.0×	691 0.5×	1.3k 1.0×	756 1.2×	325 0.5×	50	6.0k
Daniel S. Straus United States	30	2.9k 0.8×	897 0.6×	787 0.6×	576 0.9×	500 0.8×	75	4.8k
Christina C. Leslie United States	49	4.9k 1.4×	586 0.4×	1.3k 1.0×	1.3k 2.0×	680 1.1×	100	7.8k
Hitoshi Ohmori Japan	37	2.0k 0.6×	604 0.4×	1.8k 1.4×	431 0.7×	376 0.6×	207	5.1k
Warren S.‐L. Liao United States	38	3.1k 0.9×	1.2k 0.8×	803 0.6×	412 0.6×	488 0.8×	79	5.0k
Charles Kunsch United States	24	2.2k 0.6×	761 0.5×	1.2k 0.9×	354 0.5×	322 0.5×	35	4.3k
Jaladanki N. Rao United States	49	3.7k 1.0×	1.3k 0.9×	415 0.3×	235 0.4×	553 0.9×	127	5.1k
Lucia Rohrer Switzerland	36	1.9k 0.5×	779 0.5×	1.3k 1.0×	518 0.8×	1.8k 2.9×	69	5.4k

Countries citing papers authored by Gabriel Pascual

Since Specialization

Citations

This map shows the geographic impact of Gabriel Pascual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Pascual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Pascual more than expected).

Fields of papers citing papers by Gabriel Pascual

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Pascual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Pascual. The network helps show where Gabriel Pascual may publish in the future.

Co-authorship network of co-authors of Gabriel Pascual

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Pascual. A scholar is included among the top collaborators of Gabriel Pascual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Pascual. Gabriel Pascual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pipek, Leonardo Zumerkorn, et al.. (2025). Acetylcholinesterase Inhibitors for Delirium Prevention: A Systematic Review and Meta-Analysis. Critical Care Medicine. 53(10). e2054–e2061. 1 indexed citations

Gilman, Morgan S. A., et al.. (2019). Transient opening of trimeric prefusion RSV F proteins. Nature Communications. 10(1). 2105–2105. 73 indexed citations

Perry, Stuart T., et al.. (2019). Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations. Journal of Visualized Experiments. 1 indexed citations

Li, Xinyi, Wouter Koudstaal, Lauren Fletcher, et al.. (2019). Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology. Acta Neuropathologica. 137(5). 825–836. 44 indexed citations

Ritschel, Tina, Gabriel Pascual, Just P. J. Brakenhoff, et al.. (2018). Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies. PLoS Pathogens. 14(3). e1006935–e1006935. 54 indexed citations

Ameijde, Jeroen van, R W Janson, Jarek Juraszek, et al.. (2018). Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau. Acta Neuropathologica Communications. 6(1). 59–59. 15 indexed citations

Zhang, H., Xueyong Zhu, Gabriel Pascual, et al.. (2018). Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody. Structure. 26(12). 1626–1634.e4. 8 indexed citations

Arija, Victoria, Felipe Villalobos, Roser Pedret, et al.. (2018). Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial. Health and Quality of Life Outcomes. 16(1). 184–184. 87 indexed citations

Stender, Joshua D., Gabriel Pascual, Wen Liu, et al.. (2012). Control of Proinflammatory Gene Programs by Regulated Trimethylation and Demethylation of Histone H4K20. Molecular Cell. 48(1). 28–38. 186 indexed citations

10.

Zhou, Wenlai, Ping Zhu, Jianxun Wang, et al.. (2008). Histone H2A Monoubiquitination Represses Transcription by Inhibiting RNA Polymerase II Transcriptional Elongation. Molecular Cell. 29(1). 69–80. 304 indexed citations

11.

Wang, Xiangting, S Arai, Xiaoyuan Song, et al.. (2008). Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 454(7200). 126–130. 805 indexed citations breakdown →

12.

Pascual, Gabriel, et al.. (2008). Narrowing in on Cardiovascular Disease: The Atheroprotective Role of Peroxisome Proliferator–Activated Receptor γ. Trends in Cardiovascular Medicine. 18(2). 39–44. 14 indexed citations

13.

Pascual, Gabriel, Mercedes Ricote, & Andrea L. Hevener. (2007). Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes. Expert Opinion on Therapeutic Targets. 11(11). 1503–1520. 10 indexed citations

14.

Pascual, Gabriel, Sumito Ogawa, Amir Gamliel, et al.. (2007). Anti‐Inflammatory and Antidiabetic Roles of PPARγ. Novartis Foundation symposium. 286. 183–199. 31 indexed citations

15.

Ghisletti, Serena, Wendy Huang, Sumito Ogawa, et al.. (2007). Parallel SUMOylation-Dependent Pathways Mediate Gene- and Signal-Specific Transrepression by LXRs and PPARγ. Molecular Cell. 25(1). 57–70. 451 indexed citations

16.

Pascual, Gabriel & Christopher K. Glass. (2006). Nuclear receptors versus inflammation: mechanisms of transrepression. Trends in Endocrinology and Metabolism. 17(8). 321–327. 170 indexed citations

17.

Lehrke, Michael, Gabriel Pascual, Christopher K. Glass, & Mitchell A. Lazar. (2005). Gaining weight: the Keystone Symposium on PPAR and LXR. Genes & Development. 19(15). 1737–1742. 24 indexed citations

18.

Ogawa, Sumito, Jean Lozach, Christopher Benner, et al.. (2005). Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors. Cell. 122(5). 707–721. 533 indexed citations breakdown →

19.

Pascual, Gabriel, Sumito Ogawa, Amir Gamliel, et al.. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature. 437(7059). 759–763. 1030 indexed citations breakdown →

20.

Mercurio, Frank, Brion W. Murray, Andrej Shevchenko, et al.. (1999). IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex. Molecular and Cellular Biology. 19(2). 1526–1538. 288 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact